Skip to main content
Insight

UK patent court ruling allows new entrant into pharmaceutical market

David Knight
21/04/2017
News on a recent patent dispute concerning a very popular prescription drug and a concerted patent strategy

In a recent patent dispute concerning a very popular prescription drug and a concerted patent strategy by the current market leader, a ruling of the High Court has enabled a new market entrant to join the market.

Our Intellectual Property blog, SnIPpets, has just posted a blog (here) about the recent High Court decision in Fujifilm Kyowa Kirin Biologics Co Ltd & Ors v AbbVie Biotechnology Ltd [2017] EWHC 395 (Pat). The blog focuses on AbbVie Biotechnolgy's conduct in relation to its dosage patent applications.

Sign up to our email digest

Click to subscribe or manage your email preferences.

SUBSCRIBE